Quote: CNXPHARMA
22747.20
+114.45
(+0.51%)
as on
Day's Low
Day's High
0.74%
Downside
0.00%
Upside
52 Week's Low
52 Week's High
15.94%
Downside
3.77%
Upside
Top 5 Pulling UP β²
| Stock Name | Market Price | Chn % |
|---|---|---|
| βΉ176.15 | 3.69% | |
| βΉ1208.5 | 1.3% | |
| βΉ1839.5 | 1.07% | |
| βΉ391.35 | 0.93% | |
| βΉ2121.7 | 0.9% |
Top 5 Pulling
| Stock Name | Market Price | Chn % |
|---|---|---|
| βΉ27975 | -1.79% | |
| βΉ1414.5 | -0.59% | |
| βΉ2928.2 | -0.35% | |
| βΉ1709.5 | -0.33% | |
| βΉ1250.6 | -0.22% |
| Company | Market Cap (in Cr) | Analyst Rating | Market Price | Change % |
|---|---|---|---|---|
| βΉ4,12,949.54 | BUY | βΉ1731.6 | 0.61% | |
| βΉ1,68,413.27 | HOLD | βΉ6360.5 | 0.26% | |
| βΉ1,30,247.34 | BUY | βΉ3868 | 0.51% | |
| βΉ1,21,238.38 | BUY | βΉ1513.6 | 0.85% | |
| βΉ1,04,612.57 | HOLD | βΉ1250.6 | 0.22% | |
| βΉ96,055.65 | BUY | βΉ2121.7 | 0.9% | |
| βΉ92,075.44 | HOLD | βΉ917.15 | 0.23% | |
| βΉ89,355.79 | BUY | βΉ2182 | 0.8% | |
| βΉ69,289.63 | BUY | βΉ1208.5 | 1.3% | |
| βΉ65,324.34 | HOLD | βΉ5509 | 0.83% | |
| βΉ60,530.63 | BUY | βΉ27975 | 1.79% | |
| βΉ59,945.67 | HOLD | βΉ1111.4 | 0.09% | |
| βΉ57,179.53 | BUY | βΉ2039.3 | 0.65% | |
| βΉ51,840.76 | BUY | βΉ391.35 | 0.93% | |
| βΉ36,711.08 | BUY | βΉ2928.2 | 0.35% |
Sector
Market Cap
The Nifty Pharma Index is a sectoral index on the National Stock Exchange (NSE) that captures the performance of the pharmaceutical sector in the Indian economy. It includes 10 leading pharmaceutical companies listed on the NSE, representing a broad spectrum of activities in the pharma industry, from drug manufacturing to biotechnology. The index serves as a benchmark for investors seeking to track the health and performance of the Indian pharmaceutical sector.
The Nifty Pharma Index was launched on April 1, 2005, with a base date of January 1, 2001, and a base value of 1000. Since its inception, the index has grown significantly, reflecting the rapid development and global expansion of the Indian pharmaceutical industry. The Nifty Pharma Index is owned and managed by NSE Indices Limited, which ensures that it remains an accurate representation of the sector through regular reviews and adjustments.
The selection of companies in the Nifty Pharma Index is based on specific criteria to ensure the inclusion of the most relevant and liquid stocks. The eligibility criteria are as follows:
1. Listing on NSE: The company must be listed on the National Stock Exchange (NSE).
2. Inclusion in Nifty 500: The company must be part of the Nifty 500 Index.
3. Sector Classification: The company must belong to the pharmaceutical sector, including activities such as drug manufacturing, biotechnology, and related fields.
4. Trading Frequency: The stock must have a trading frequency of at least 90% over the past six months.
5. Listing History: The stock must have a listing history of at least six months. However, a recently listed company (IPO) can be included if it meets the above criteria for a period of three months.
6. Free-Float Market Capitalization: Stocks are weighted based on their free-float market capitalization, ensuring that only the shares available for public trading are considered.
The Nifty Pharma Index is a sectoral index on the NSE that tracks the performance of the top pharmaceutical companies in India.
The index was created to provide a specific benchmark for the pharmaceutical sector, helping investors track the performance of this crucial industry.
Companies are selected based on their listing on the NSE, inclusion in the Nifty 500, sector classification, trading frequency, and free-float market capitalization criteria.
The index is reviewed semi-annually, with changes implemented from the last trading day of March and September.
Yes, new companies can be added if they meet the eligibility criteria, including a trading history and high trading frequency.
The index includes companies involved in drug manufacturing, biotechnology, and other related pharmaceutical activities.
The base date (January 1, 2001) and base value (1000) serve as reference points for calculating the index's value over time, allowing for consistent performance measurement.
Investors can use the Nifty Pharma Index as a benchmark to evaluate the performance of their investments in the pharmaceutical sector or to invest in products that track the index, such as ETFs and index funds.
Yes, there are ETFs and mutual funds designed to track the performance of the Nifty Pharma Index, offering investors a way to invest in this sector through a diversified portfolio.